Annual EBITDA
-$50.55 M
-$1.62 M-3.30%
31 December 2023
Summary:
Fractyl Health Common Stock annual earnings before interest, taxes, depreciation & amortization is currently -$50.55 million, with the most recent change of -$1.62 million (-3.30%) on 31 December 2023. During the last 3 years, it has fallen by -$22.34 million (-79.21%). GUTS annual EBITDA is now -79.21% below its all-time high of -$28.21 million, reached on 01 December 2020.GUTS EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBITDA
-$23.59 M
-$792.00 K-3.47%
01 September 2024
Summary:
Fractyl Health Common Stock quarterly earnings before interest, taxes, depreciation & amortization is currently -$23.59 million, with the most recent change of -$792.00 thousand (-3.47%) on 01 September 2024. Over the past year, it has dropped by -$9.80 million (-71.04%). GUTS quarterly EBITDA is now -245.67% below its all-time high of -$6.82 million, reached on 01 September 2020.GUTS Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBITDA
-$80.81 M
-$9.80 M-13.79%
01 September 2024
Summary:
Fractyl Health Common Stock TTM earnings before interest, taxes, depreciation & amortization is currently -$80.81 million, with the most recent change of -$9.80 million (-13.79%) on 01 September 2024. Over the past year, it has dropped by -$31.87 million (-65.12%). GUTS TTM EBITDA is now -1084.38% below its all-time high of -$6.82 million, reached on 01 September 2020.GUTS TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
GUTS EBITDA Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | -3.3% | -71.0% | -65.1% |
3 y3 years | -79.2% | -173.5% | -400.3% |
5 y5 years | - | - | - |
GUTS EBITDA High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3 years | -79.2% | at low | -173.5% | at low | -400.3% | at low |
5 y | 5 years | -79.2% | at low | -245.7% | at low | -1084.4% | at low |
alltime | all time | -79.2% | at low | -245.7% | at low | -1084.4% | at low |
Fractyl Health Common Stock EBITDA History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sept 2024 | - | -$23.59 M(+3.5%) | -$80.81 M(+13.8%) |
June 2024 | - | -$22.79 M(+6.1%) | -$71.01 M(+18.3%) |
Mar 2024 | - | -$21.49 M(+66.0%) | -$60.01 M(+18.7%) |
Dec 2023 | -$50.55 M(+3.3%) | -$12.94 M(-6.1%) | -$50.55 M(+3.3%) |
Sept 2023 | - | -$13.79 M(+16.9%) | -$48.94 M(+5.0%) |
June 2023 | - | -$11.79 M(-2.0%) | -$46.62 M(+33.9%) |
Mar 2023 | - | -$12.03 M | -$34.83 M |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Dec 2022 | -$48.93 M(+35.0%) | - | - |
Dec 2022 | - | -$11.33 M(-1.2%) | -$22.80 M(-1.5%) |
Sept 2022 | - | -$11.47 M(-1.7%) | -$23.14 M(+14.0%) |
Dec 2021 | -$36.25 M(+28.5%) | -$11.67 M(+35.3%) | -$20.29 M(+25.6%) |
Sept 2021 | - | -$8.62 M(+14.5%) | -$16.15 M(+12.5%) |
Dec 2020 | -$28.21 M(-2.9%) | -$7.53 M(+10.4%) | -$14.35 M(+110.4%) |
Sept 2020 | - | -$6.82 M | -$6.82 M |
Dec 2019 | -$29.06 M | - | - |
FAQ
- What is Fractyl Health Common Stock annual earnings before interest, taxes, depreciation & amortization?
- What is the all time high annual EBITDA for Fractyl Health Common Stock?
- What is Fractyl Health Common Stock annual EBITDA year-on-year change?
- What is Fractyl Health Common Stock quarterly earnings before interest, taxes, depreciation & amortization?
- What is the all time high quarterly EBITDA for Fractyl Health Common Stock?
- What is Fractyl Health Common Stock quarterly EBITDA year-on-year change?
- What is Fractyl Health Common Stock TTM earnings before interest, taxes, depreciation & amortization?
- What is the all time high TTM EBITDA for Fractyl Health Common Stock?
- What is Fractyl Health Common Stock TTM EBITDA year-on-year change?
What is Fractyl Health Common Stock annual earnings before interest, taxes, depreciation & amortization?
The current annual EBITDA of GUTS is -$50.55 M
What is the all time high annual EBITDA for Fractyl Health Common Stock?
Fractyl Health Common Stock all-time high annual earnings before interest, taxes, depreciation & amortization is -$28.21 M
What is Fractyl Health Common Stock annual EBITDA year-on-year change?
Over the past year, GUTS annual earnings before interest, taxes, depreciation & amortization has changed by -$1.62 M (-3.30%)
What is Fractyl Health Common Stock quarterly earnings before interest, taxes, depreciation & amortization?
The current quarterly EBITDA of GUTS is -$23.59 M
What is the all time high quarterly EBITDA for Fractyl Health Common Stock?
Fractyl Health Common Stock all-time high quarterly earnings before interest, taxes, depreciation & amortization is -$6.82 M
What is Fractyl Health Common Stock quarterly EBITDA year-on-year change?
Over the past year, GUTS quarterly earnings before interest, taxes, depreciation & amortization has changed by -$9.80 M (-71.04%)
What is Fractyl Health Common Stock TTM earnings before interest, taxes, depreciation & amortization?
The current TTM EBITDA of GUTS is -$80.81 M
What is the all time high TTM EBITDA for Fractyl Health Common Stock?
Fractyl Health Common Stock all-time high TTM earnings before interest, taxes, depreciation & amortization is -$6.82 M
What is Fractyl Health Common Stock TTM EBITDA year-on-year change?
Over the past year, GUTS TTM earnings before interest, taxes, depreciation & amortization has changed by -$31.87 M (-65.12%)